Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PharmaCielo ( (TSE:PCLO) ) has issued an update.
PharmaCielo announced its plans to issue shares to settle certain debts and interest payments. The company has issued 2,000,000 common shares to settle $200,000 of debt with service providers and 10,259,041 shares to fulfill nearly $978,000 in interest payments for its secured debentures. This action reflects PharmaCielo’s strategic financial management and its commitment to maintaining healthy relationships with its creditors.
More about PharmaCielo
PharmaCielo Ltd. is a global company based in Canada, focused on the ethical and sustainable cultivation, processing, and supply of all-natural, pharmaceutical-grade medical cannabis products. The company’s main subsidiary, PharmaCielo Colombia Holdings S.A.S., operates from its cultivation and processing center in Rionegro, Colombia, and aims to supply the international marketplace.
YTD Price Performance: 12.00%
Average Trading Volume: 5,954
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.59M
See more data about PCLO stock on TipRanks’ Stock Analysis page.